AI assistant
SOLARA ACTIVE PHARMA SCIENCES LIMITED — AGM Information 2023
Sep 15, 2023
61842_rns_2023-09-15_ab8e3297-1ffb-4adf-a372-7f8cf584aa2e.pdf
AGM Information
Open in viewerOpens in your device viewer
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block
27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in
Keelakottaiyur Village, Melakottaiyur (Post)
September 15, 2023
The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001
The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051
Scrip Code: 541540
Scrip Code: SOLARA
Dear Sir / Madam,
Sub: Sixth Annual General Meeting of the Company and disclosure under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
We wish to inform you that the Sixth Annual General Meeting (“AGM”) of the Company was held on Friday, September 15, 2023, through Video Conferencing.
Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Thanking you,
Yours faithfully,
For Solara Active Pharma Sciences Limited
SUDDAPALLI MURALIKRISHNA
Digitally signed by SUDDAPALLI MURALIKRISHNA Date: 2023.09.15 12:32:15 +05'30'
S. Murali Krishna Company Secretary
Encl.: as above
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in
SUMMARY OF PROCEEDINGS OF THE SIXTH ANNUAL GENERAL MEETING OF THE COMPANY HELD THROUGH VIDEO CONFERENCING ON FRIDAY, SEPTEMBER 15, 2023, FROM 9:30 A.M TO 10:38 A.M.
Present:
Mr. R. Ramakrishnan Independent Director & Audit Committee Chairman Dr. Kausalya Santhanam Independent Director & Stakeholders Committee Chairperson Mr. Kartheek Raju Non-Executive Director Mr. Poorvank Purohit Managing Director & CEO Mr. S. Murali Krishna Company Secretary Mr. Sathya Koushik Partner, M/s. Deloitte Haskins & Sells LLP, Chartered Accountants Statutory Auditors of the Company Mr. Preetham Hebbar Practising Company Secretary - Scrutinizer for the Voting process Mr. A Mohan Kumar Secretarial Auditor
Mr. R. Ramakrishnan was elected as Chairman for the meeting, and he welcomed the Members to the Sixth Annual General Meeting (AGM) of the Company and introduced the Directors and other invitees present in the meeting to the Members. Company Secretary confirmed that the requisite quorum was present and requested Chairman to conduct the meeting. Chairman called the meeting to order.
The members were informed that the requisite Statutory Registers and other documents referred to in the Notice of the AGM were available for online inspection on request by the Members. Members who were present at the AGM and had not cast their votes electronically through remote e-voting were provided an opportunity to cast their votes through e-voting during the meeting.
Mr. Poorvank Purohit, Managing Director & CEO, delivered his speech.
Thereafter, Mr. R. Ramakrishnan, Chairman of the meeting, invited queries from the Members of the Company, which was responded by Mr. Poorvank Purohit.
With the consent of the Members present, the Notice convening the AGM, the Report of the Board of Directors and the accounts for the Financial Year ended March 31, 2023, were taken as read.
Mr. S. Murali Krishna further informed that as per the provisions of the Companies Act, 2013 and SEBI Listing Regulations, the Company had provided remote e-voting facility to all the Members through CDSL E-Voting platform to vote on all the resolutions proposed to be passed at the Meeting.
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel : +91 44 43446700 Fax : +91 44 47406190 E-mail : [email protected] www.solara.co.in
The cut-off date for determining the members who are entitled to vote through e-voting facility as well as voting at the meeting was Friday, September 8, 2023. The e-voting period commenced on September 12, 2023, at 9.00 a.m. and ended on September 14, 2023, at 5.00 p.m.
The Chairman informed that the Board of Directors of the Company had appointed Mr. Preetham Hebbar, Practicing Company Secretary, as Scrutinizer for the meeting.
The following items of business as per the Notice of AGM dated July 5, 2023, were transacted at the meeting:
| Item No. |
Description / Resolutions | Type of Resolution |
|---|---|---|
| Ordinary Business | ||
| 1 | Adoption of Audited Financial Statements for the Financial Year ended March 31, 2023 |
Ordinary Resolution |
| 2 | Re-Appointment of Mr. Ankur Thadani, retiring director, as a Non- Executive Director |
Ordinary Resolution |
| 3 | Re-Appointment of Statutory Auditors for the second term of four years | Ordinary Resolution |
| Special Business | ||
| 4 | Ratification of remuneration payable to the Cost Auditor for the financial year 2022-23 |
Ordinary Resolution |
| 5 | Approval for Material Related Party Transactions/ Contracts/ Arrangements with Strides Pharma Science Limited up to ₹ 300 Crores |
Ordinary Resolution |
| 6 | Appointment of Mr. Kartheek Chintalapati Raju (DIN: 02921819) as a Non‑Executive(Non‑Independent)Director of the Company |
Ordinary Resolution |
| 7 | Appointment of Mr. Poorvank Purohit (DIN: 10158900) as a Managing Director & Chief Executive Officer (CEO) of the Company |
Special Resolution |
Mr. S. Murali Krishna stated that the consolidated results of the voting would be declared along with the Scrutinizer’s Report to the Stock Exchanges where the shares of the Company are listed and posted on the Company’s website within two days.
Mr. R. Ramakrishnan, Chairman of the meeting, thanked the Members and concluded the meeting.
For Solara Active Pharma Sciences Limited
SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2023.09.15 12:33:09 +05'30'
S. Murali Krishna Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942